13F-HR filed by ACUTA CAPITAL PARTNERS, LLC
ACUTA CAPITAL PARTNERS, LLC filed this 13F-HR for the quarter ended 2021-03-31, filed 2021-05-17, with 46 holding rows worth $277,340,000.
- Accession
- 0001104659-21-067632
- Filer
- CIK 1582844
- Filed
- 2021-05-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2021
A holdings report, 46 entries on the cover page, a total value of $277,340,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $277,340,000 with VALUE read as thousands by filing date, 13F file number 028-16527. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VISTAGEN THERAPEUTICS INC | 92840H202 | COM | 12,295,767 | $26,190,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 1,017,524 | $20,961,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 536,820 | $15,176,000 | thousands by filing date | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 1,095,000 | $9,899,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 1,579,093 | $9,759,000 | thousands by filing date | |
| 89BIO INC | 282559103 | COM | 393,548 | $9,319,000 | thousands by filing date | |
| BCLS ACQUISITION CORP | G0904B105 | CMN | 843,122 | $8,912,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 118,500 | $8,870,000 | thousands by filing date | |
| CURIS INC | 231269200 | COM | 767,500 | $8,688,000 | thousands by filing date | |
| SEELOS THERAPEUTICS INC | 81577F109 | COM | 1,719,812 | $8,582,000 | thousands by filing date | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 287,000 | $8,337,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 317,730 | $8,007,000 | thousands by filing date | |
| VINCERX PHARMA INC | 92731L106 | COM NEW | 394,000 | $7,604,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 412,500 | $7,384,000 | thousands by filing date | |
| ATHIRA PHARMA INC | 04746L104 | COM | 400,000 | $7,360,000 | thousands by filing date | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 622,500 | $7,333,000 | thousands by filing date | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 108,000 | $7,161,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 661,565 | $7,105,000 | thousands by filing date | |
| CHIMERIX INC COM | 16934W106 | Stock | 707,830 | $6,823,000 | thousands by filing date | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 357,689 | $5,787,000 | thousands by filing date | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 407,055 | $5,752,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 255,180 | $5,706,000 | thousands by filing date | |
| VERASTEM INC | 92337C104 | COM | 2,293,388 | $5,665,000 | thousands by filing date | |
| JIYA ACQUISITION CORP | 47760M102 | CMN | 562,500 | $5,535,000 | thousands by filing date | |
| PRAXIS PRECISION MEDICINES I | 74006W108 | COM | 154,229 | $5,053,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 113,161 | $4,856,000 | thousands by filing date | |
| CATALYST BIOSCIENCES INC | 14888D208 | COM | 939,500 | $4,735,000 | thousands by filing date | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 200,289 | $4,446,000 | thousands by filing date | |
| HEALTH SCIENCES ACQ CORP 2 | G4411D109 | ORD SHS | 392,500 | $4,392,000 | thousands by filing date | |
| CLEARSIDE BIOMEDICAL INC | 185063104 | COM | 1,614,000 | $3,987,000 | thousands by filing date | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 381,145 | $3,872,000 | thousands by filing date | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 823,000 | $3,724,000 | thousands by filing date | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 90,000 | $3,314,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 97,574 | $3,089,000 | thousands by filing date | |
| VINCERX PHARMA INC | 92731L114 | *W EXP 12/24/202 | 520,000 | $2,101,000 | thousands by filing date | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 82,000 | $1,788,000 | thousands by filing date | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 45,000 | $1,748,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 9,000 | $1,542,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 42,500 | $1,448,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 315,341 | $1,432,000 | thousands by filing date | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 14,000 | $1,396,000 | thousands by filing date | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 20,000 | $868,000 | thousands by filing date | |
| NOVAVAX INC | 670002401 | COM NEW | 3,136 | $569,000 | thousands by filing date | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 13,856 | $456,000 | thousands by filing date | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 78,000 | $360,000 | thousands by filing date | |
| NUVATION BIO INC | 67080N119 | WARR | 93,332 | $249,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-21-067632 | this filing | 2021-05-17 | acceptance time not in the bulk data set |